Are we now entering the age of proteomics the way we did with genomics thirty years ago?
We were told we should talk to today’s guest by four people in one week. He’s Omid Farokhzad, CEO and Founder of Seer Inc. When we did, we understood why.
Seer offers its customers the chance to “see the proteome in a way that’s never been possible before.” So what does that mean?
This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit
www.mendelspod.com/subscribe
Mendelspod Podcast